Nuventra is a leading clinical pharmacology consulting firm that specializes in pharmacokinetics (PK), pharmacodynamics (PD), and pharmacometrics. They partner with pharmaceutical and biotechnology companies of all sizes, from startups to large pharma, to optimize drug development strategies and navigate regulatory pathways. Nuventra's expertise spans early Phase I trials through late-stage development and post-marketing support, helping clients make informed decisions to advance their drug candidates efficiently and effectively.
Serves as the central hub for Nuventra's operations, scientific leadership, project management, and corporate administration.
Modern office facilities designed to support scientific collaboration, data analysis, and client communication. Located in a prominent research park.
Nuventra fosters a scientifically-driven, collaborative, and client-focused work environment. The culture emphasizes expertise, precision, and innovation in drug development consulting, with a team of highly specialized pharmacologists and scientists.
The Durham HQ benefits from its location in the Research Triangle Park, providing access to a rich talent pool, proximity to numerous pharmaceutical and biotech companies, and a vibrant research community.
Nuventra offers its specialized clinical pharmacology, pharmacokinetic, and pharmacometric consulting services to pharmaceutical and biotechnology companies globally. While its physical offices are strategically located within the United States, its project reach and client base are international, supporting drug development programs across diverse geographical regions, including North America, Europe, and Asia.
2525 Meridian Parkway, Suite 275
Durham
NC
USA
Address: 1201 N Orange St, Suite 700, Wilmington, DE 19801
To provide localized support and expertise for pharmaceutical and biotech clients in Delaware and the broader East Coast region, facilitating closer collaboration.
Address: 300 Interlocken Blvd, Suite 340, Broomfield, CO 80021
To cater to the expanding life sciences sector in Colorado and surrounding states, providing accessible consulting services for drug development programs.
Address: 101 Arrandale Blvd, Suite 210, Exton, PA 19341
To be strategically positioned within the Greater Philadelphia pharmaceutical and biotech ecosystem, enhancing client engagement and service delivery.
Address: One Broadway, 14th Floor, Cambridge, MA 02142
To offer specialized clinical pharmacology and PK/PD consulting directly within a major global hub for biomedical innovation, fostering collaborations and supporting cutting-edge drug development.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Nuventra Pharma Sciences' leadership includes:
Nuventra Pharma Sciences has been backed by several prominent investors over the years, including:
The most significant corporate event for Nuventra in the last 12 months was its acquisition by Avania, a global medical technology contract research organization (CRO), in September 2023. Nuventra's existing executive team largely continues to lead its specialized operations under Avania. No other major, publicly announced executive hires or exits within Nuventra's core leadership team have been noted in this period.
Discover the tools Nuventra Pharma Sciences uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Nuventra primarily utilizes the email format of the first initial followed by the last name. This is a common structure in professional organizations.
[first_initial][last]@nuventra.com
Format
jdoe@nuventra.com
Example
90%
Success rate
Avania • September 7, 2023
Avania, a leading global medical technology CRO, announced its acquisition of Nuventra, a specialist clinical pharmacology consulting firm. This strategic acquisition aims to enhance Avania's offerings by integrating Nuventra's deep expertise in pharmacokinetics, pharmacodynamics, and pharmacometrics, thereby providing comprehensive support for medtech and pharmaceutical development....more
Nuventra Website (Blog/News section typical) • October 19, 2023
Following its acquisition by Avania, Nuventra emphasizes its continued commitment to providing high-level clinical pharmacology consulting. The integration allows Nuventra to leverage Avania's broader resources while maintaining its specialized focus and expert team....more
Nuventra Website Resources • Ongoing
Nuventra regularly shares expertise through white papers, case studies, and blog posts covering various aspects of clinical pharmacology, PK/PD modeling, and regulatory strategy, aimed at educating and informing the drug development community....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Nuventra Pharma Sciences, are just a search away.